MMP9 and acute coronary syndrome: Other studies have found correlations between plasma MMP-9 levels and symptom severity in patients with acute coronary syndrome, suggesting that MMP-9 could be used as a biomarker for disease progression and patient stratification (Hamed and Fattah, 2015; Kobayashi et al., 2011).